An ROS-responsive and self-accelerating drug release nanoplatform for overcoming multidrug resistance.
Chem Commun (Camb)
; 55(23): 3383-3386, 2019 Mar 14.
Article
in En
| MEDLINE
| ID: mdl-30821310
An 'on-demand' drug release and ROS-responsive nanoparticle was prepared by chemically conjugating hydrophobic α-tocopheryl succinate to hydrophilic poly(ethylene glycol) via a thioketal linker. This nanoparticle encapsulated with doxorubicin and α-tocopheryl succinate exhibited remarkable efficiency in reversing multidrug resistance both in vitro and in vivo.
Full text:
1
Database:
MEDLINE
Main subject:
Drug Carriers
/
Doxorubicin
/
Reactive Oxygen Species
/
Drug Resistance, Neoplasm
/
Nanoparticles
/
Antibiotics, Antineoplastic
Limits:
Animals
/
Humans
Language:
En
Journal:
Chem Commun (Camb)
Journal subject:
QUIMICA
Year:
2019
Type:
Article
Affiliation country:
China